VitaSignal is developing vendor evidence software and scoped institutional review services to clarify claims, local data needs and unresolved questions before the next decision.
View a synthetic exampleWatch the overview
Buyer Readiness is in private preview. Institutional engagements require an agreed scope, delivery capacity and separate authorization. Tools remain in development and are not for clinical use.
Explore VitaSignal
Vendor software and institutional services have separate scopes. VitaSignal recommends; the health system decides. No clinical use or live integration is established.
Vendor preparation, local data review and institutional governance are not interchangeable. VitaSignal is developing vendor evidence software and scoped institutional review services for these questions, while keeping decisions with the health system.
The questions guiding our work
A prepared vendor record is not local validation. A recommendation is not authorization for clinical use.
Offering guide
Vendor preparation, institutional feasibility and governance evaluation address different needs. Each has its own scope and intended deliverable. They are optional purchases, not a required sequence.
Buyer Readiness is in private preview. Institutional engagements require an agreed scope, delivery capacity and separate authorization. Tools remain in development and are not for clinical use.
For clinical AI and digital health vendors
Private preview
Vendor-facing software intended to organize a product's intended use, claims, supporting sources, limitations and unresolved questions into a versioned Buyer Readiness Record.
A prepared record is not independent validation, institutional approval or evidence of local suitability.
Explore Buyer ReadinessAsk about a guided walkthroughFor healthcare institutions and evaluation teams
Scope discussion
Define the workflow, data-pathway questions, approval needs and unresolved evidence for one institutional use case. The proposed deliverable is an institution-specific feasibility assessment with scoped next steps.
A starting review may use approved nonpatient documents and stakeholder conversations. Scope, handling terms, capacity and price must be agreed before work starts.
Individually scoped institutional work
Discuss a feasibility reviewFor institutions authorizing a defined evaluation
Separate authorization
A separately scoped evaluation intended to document evidence, limitations, risks and recommendations in a Governance Decision Package for a defined local use.
Qualified reviewers, an agreed protocol and applicable approvals are required. Findings may be blocked or inconclusive, or recommend pausing or stopping. The institution retains decision authority.
No clinical-use or deployment authority
Discuss an evaluationA vendor record does not require or guarantee an institutional engagement or a favorable finding. Preparing a vendor's material also does not establish independence for a later evaluation of that product.
VitaSignal's existing EHR and Data Pathway prototype is supporting infrastructure for institutional reviews. Its working application name is VitaSignal EHR Data & AI Evaluation Readiness.
The intended functions cover use-case setup, authorized read-only data pathways, field availability, data quality, provenance, reviewer controls and a versioned EHR Data Readiness Summary. Documentation-pattern review belongs only where the use case and approved information justify it.
The app remains a private prototype. No production connector, completed local integration, security acceptance or clinical deployment is represented.
Explore the data-readiness approachApp access, data permissions and any handoff require their own authorization. Shared sign-in, automatic record transfer and a connected product workflow are not established.
Buyer Readiness is in private preview. Institutional engagements require an agreed scope, delivery capacity and separate authorization. Tools remain in development and are not for clinical use. The deliverables below describe intended scope.
None automatically establishes clinical safety, effectiveness, local suitability or permission to deploy. Vendor records require institutional review. Export/import and replay are under development, not proven live integration.
Clinical AI Buyer Readiness has its own standalone website at clinicalready.vitasignal.ai, currently in private preview. Its vendor-prepared records still require institution-owned review; they do not establish local suitability or authorize clinical use.
App access, data permissions and any handoff require their own authorization. Shared sign-in, automatic record transfer and a connected product workflow are not established.
Same-provider vendor-paid preparation is not independent third-party evaluation.
VitaSignal was founded by Alexis Collier, a healthcare administrator and clinical AI researcher focused on clinical AI evidence, healthcare workflows and accountable implementation.
Tools remain in development. Any future evaluation needs a defined scope, data boundaries, accountable reviewers and stopping conditions before work starts.
Explore the offeringsTell us whether you are preparing vendor evidence, considering an institutional feasibility review or exploring a separately authorized evaluation. An initial discussion helps identify the relevant scope and next decision. It does not include an assessment, app access or an engagement commitment. Keep the inquiry nonconfidential.
Request a scope discussion